Athenex inc.

Major-Pharmaceuticals

ATNX


1001 Main Street
Buffalo , NY 14203

Executive/
Director

Price

  • Last Close
  • $ 0.18
    $ -0.04 -19.63 %
    Feb 14, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 3,273,777
  • Market Cap Full
  • $ 1.6M
  • Shares Outstanding
  • 8.7M
    Mar 13, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - 7% -3.5% -5% -61.6% -37% 18.9% -
Q2 - - 27.4% 9.1% 60.6% 4% 7.4% -52.3% - -
Q3 - - 9.4% -20.4% -38.3% 8% -34.9% -34.2% - -
Q4 - - -8.6% -18.1% 25.9% -7.5% -54.8% -45% - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 23.7% -3.8% - - - - - - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%-20%19%-26%-88%-89%19%0%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022
Q1 - - - -0.12 -0.53 -0.24 -0.27 -3.2
Q2 - - 0.88 -0.58 -0.44 -0.5 -0.33 -5.6
Q3 - - 0.30 -0.7 -0.45 -0.44 -0.33 -2.8
Q4 - - 0.49 -0.42 -0.25 -0.54 -19.84 -4.21
A 0 0 1.7 -1.8 -1.7 -1.7 -38.4 -15.8

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 67 81.6 93.5 110.4 8.7
Jun 63.5 67.1 81.6 93.5 111.8 -
Sep 66.3 77.3 81.7 109.3 121.6 -
Dec 66.9 77.5 93.3 109.3 157.4 -

Financial Ratios

20202019201820172016
Asset Management
Inventory / Stock Turnover 3.3 2.1 1.6 1.5 4.7
Fixed Asset Turnover 1.6 1.3 1.5 0.7 0.4
Total Asset Turnover 0.4 0.3 0.4 0.3 0.2
Leverage
Debt Ratio 0.5 0.2 0.3 - 0.6
Debt – Equity Ratio 0.9 0.3 0.4 - 0.9
Interest Coverage -5.5 -28.4 13.5 -5.2 -43.6
Equity multiplier 0.6 0.5 0.5 0.6 1.6